{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:52:53Z","timestamp":1777535573141,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.drugalcdep.2017.07.029","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T15:59:41Z","timestamp":1503071981000},"page":"387-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Synthetic cannabinoids found in \u201cspice\u201d products alter body temperature and cardiovascular parameters in conscious male rats"],"prefix":"10.1016","volume":"179","author":[{"given":"Charles W.","family":"Schindler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin R.","family":"Gramling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Justinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B.","family":"Thorndike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0005","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/cn400035r","article-title":"The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse","volume":"4","author":"Banister","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acschemneuro.5b00107","article-title":"Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135","volume":"6","author":"Banister","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1124\/jpet.113.206003","article-title":"Differential drug\u2013drug interactions of the synthetic cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy","volume":"346","author":"Brents","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jpeds.2015.06.001","article-title":"Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients","volume":"167","author":"Clark","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11920-016-0694-1","article-title":"Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal","volume":"18","author":"Cooper","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200402000-00001","article-title":"Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development","volume":"15","author":"De Vry","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2012.07.011","article-title":"Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project","volume":"39","author":"Deluca","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0045","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-3565(25)24023-X","article-title":"Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212","volume":"271","author":"Fan","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1476-5381.1977.tb16748.x","article-title":"The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at different ambient temperatures","volume":"60","author":"Fennessy","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1476-5381.1982.tb08802.x","article-title":"Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol","volume":"75","author":"Fitton","year":"1982","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bjp.0704100","article-title":"Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive transgenic rats","volume":"133","author":"Gardiner","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjp.0704750","article-title":"Influence of the CB(1) receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats","volume":"136","author":"Gardiner","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0070","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1476-5381.2009.00363.x","article-title":"Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats","volume":"158","author":"Gardiner","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0075","first-page":"343","article-title":"Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus","volume":"66","author":"Grzeda","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0080","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","article-title":"Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings","volume":"108","author":"Hermanns-Clausen","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0085","first-page":"120607","article-title":"A unique case of cardiac arrest following K2 abuse","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"Case Rep. Cardiol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0706195","article-title":"Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats","volume":"145","author":"Kwolek","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0095","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.HYP.29.5.1204","article-title":"Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats","volume":"29","author":"Lake","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00210-010-0497-6","article-title":"Involvement of central beta2-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats","volume":"381","author":"Malinowska","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0115","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1111\/j.1476-5381.2011.01747.x","article-title":"Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?","volume":"165","author":"Malinowska","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0120","doi-asserted-by":"crossref","first-page":"e1622","DOI":"10.1542\/peds.2010-3823","article-title":"Myocardial infarction associated with use of the synthetic cannabinoid K2","volume":"128","author":"Mir","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(00)00231-8","article-title":"Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats","volume":"66","author":"Nava","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-3908(94)00133-D","article-title":"Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat: relation to the adrenergic system and endogenous pyrogens","volume":"34","author":"Ovadia","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.bjp.0705422","article-title":"Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats","volume":"140","author":"Padley","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1476-5381.1977.tb07535.x","article-title":"Effects of delta9-tetrahydrocannabinol on the rates of oxygen consumption of mice","volume":"60","author":"Pertwee","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0145","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/092986710790980050","article-title":"Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists","volume":"17","author":"Pertwee","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.bjp.0705725","article-title":"The complexities of the cardiovascular actions of cannabinoids","volume":"142","author":"Randall","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0155","first-page":"822","article-title":"Effects of opioids, cannabinoids, and vanilloids on body temperature","volume":"3","author":"Rawls","year":"2011","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1124\/jpet.301.3.963","article-title":"CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrr olo[3, 2, 1ij]quinolin-6-one]-induced hypothermia","volume":"301","author":"Rawls","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0170","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1111\/bph.13640","article-title":"Pharmacological mechanisms underlying the cardiovascular effects of the bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"173","author":"Schindler","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0091-3057(76)90291-4","article-title":"Hypothermia induced by delta9-tetrahydrocannabinol in rats with electrolytic lesions of preoptic region","volume":"5","author":"Schmeling","year":"1976","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0180","first-page":"302","article-title":"Blockade of delta9-thc induced hypothermia in rats","volume":"227","author":"Schmeling","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijcard.2016.04.055","article-title":"Can your heart handle the spice: a case of acute myocardial infarction and left ventricular apical thrombus","volume":"215","author":"Shah","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1996.tb15683.x","article-title":"Physiological and behavioural effects of the endogenous cannabinoid arachidonylethanolamide (anandamide), in the rat","volume":"119","author":"Stein","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0205","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/bph.13024","article-title":"Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Delta(9)-tetrahydrocannabinol in Sprague-Dawley rats","volume":"172","author":"Taffe","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2015.09.006","volume":"102","author":"Tai","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0215","series-title":"National Forensic Laboratory Information System Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reports in NFLIS, 2010\u20132013","author":"U.S. Drug Enforcement Administration, Office of Diversion Control","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0220","series-title":"National Forensic Laboratory Information System Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reports in NFLIS, 2013\u20132015","author":"U.S. Drug Enforcement Administration, Office of Diversion Control","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.02.008","article-title":"Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice","volume":"95","author":"Vigolo","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2011.11.001","article-title":"1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice","volume":"123","author":"Wiley","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2013.07.022","article-title":"Cannabinoids in disguise: delta9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles","volume":"75","author":"Wiley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2017.07.029_bib0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2016.07.016","article-title":"Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice","volume":"110","author":"Wiley","year":"2016","journal-title":"Neuropharmacology"},{"issue":"132","key":"10.1016\/j.drugalcdep.2017.07.029_bib0245","first-page":"e1325","article-title":"Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation","volume":"30","author":"Young","year":"2012","journal-title":"Am. J. Emerg. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:00:27Z","timestamp":1759827627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617304155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":49,"alternative-id":["S0376871617304155"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.07.029","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic cannabinoids found in \u201cspice\u201d products alter body temperature and cardiovascular parameters in conscious male rats","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}